BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2425678)

  • 1. Role of alveolar macrophage- and lung T cell-derived mediators in pulmonary sarcoidosis.
    Hunninghake GW
    Ann N Y Acad Sci; 1986; 465():82-90. PubMed ID: 2425678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunity of the lung--with special reference to sarcoidosis].
    Izumi T; Kitaichi M; Nagai S
    Kokyu To Junkan; 1983 Oct; 31(10):1046-56. PubMed ID: 6198702
    [No Abstract]   [Full Text] [Related]  

  • 3. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
    Hunninghake GW
    Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.
    Hunninghake GW; Gadek JE; Young RC; Kawanami O; Ferrans VJ; Crystal RG
    N Engl J Med; 1980 Mar; 302(11):594-8. PubMed ID: 6965420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The process of the formation of sarcoid granuloma].
    Dobrescu G; Dobrescu A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(3):213-7. PubMed ID: 2559456
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies of blood monocytes and alveolar macrophages in patients with sarcoidosis].
    Claus R; Nausch M; Zingler C; Klein M; Dietrich U; Diwok K
    Z Erkr Atmungsorgane; 1988; 170(2):185-7. PubMed ID: 3261065
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of the lymphocytes in sarcoidosis].
    Dumitru CD
    Rev Ig Med Muncii Med Soc Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1990; 39(1):77-9. PubMed ID: 2223728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenetic aspects of sarcoidosis. Importance of local complement synthesis in alveolar macrophages].
    Pettersen HB; Johnson E
    Tidsskr Nor Laegeforen; 1992 May; 112(12):1570-3. PubMed ID: 1615506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar T lymphocytes and pulmonary sarcoidosis.
    Hunninghake GW
    Clin Rev Allergy; 1985 May; 3(2):227-34. PubMed ID: 3886118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar macrophage lymphocyte interaction: alterations in smokers and in sarcoidosis.
    Yeager H; Lussier L; Prashad J
    Chest; 1979 Feb; 75(2 Suppl):289. PubMed ID: 312186
    [No Abstract]   [Full Text] [Related]  

  • 11. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.
    Ann Intern Med; 1981 Jan; 94(1):73-94. PubMed ID: 7004303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
    Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
    J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expansions of T lymphocyte subpopulations in the lung and corticosteroid-induced changes in patients with active pulmonary sarcoidosis.
    Rossi GA; Sacco O; Cosulich E; Balbi B; Risso A; Ravazzoni C
    Ann N Y Acad Sci; 1986; 465():130-9. PubMed ID: 3488000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
    Hancock WW; Muller WA; Cotran RS
    J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interleukin 1 secretion from alveolar macrophages in pulmonary sarcoidosis].
    Barth J; Kreipe H; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():215-6. PubMed ID: 2367368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granuloma formation and fibrosis in sarcoidosis.
    Arnoux AG; Reynolds HY
    Clin Dermatol; 1986; 4(4):22-34. PubMed ID: 3026599
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunopathogenesis and immunology of pulmonary sarcoidosis].
    Podwysocki B
    Pol Tyg Lek; 1989 Aug 21-28; 44(34-35):779-82. PubMed ID: 2535007
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigen presentation by alveolar macrophages in patients with sarcoidosis.
    Toews GB; Lem VM; Weissler JC; Nunez-Ollero G; Ball EJ; Stastny P; Lipscomb MF
    Ann N Y Acad Sci; 1986; 465():74-81. PubMed ID: 3488005
    [No Abstract]   [Full Text] [Related]  

  • 19. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
    Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
    Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.